Joseph Patrick Mcevoy MD

Dr. McEvoy is an I.W. Case Distinguished Professor of Psychiatry at the Augusta University Health in Augusta, GA. After receiving his medical degree from Vanderbilt University School of Medicine, Dr. McEvoy completed two years of training in Internal Medicine at the University of Utah Hospitals and then completed his Psychiatry Residency at Vanderbilt. He has served on the faculty at Vanderbilt, the University of Pittsburgh, and, since 1989, Duke University. 

Dr. McEvoy’s research and clinical work have focused on severe and persistent mental disorders (primarily schizophrenia, schizoaffective disorder, and bipolar disorder). He served as Co-Principal Investigator and Project Medical Officer for the CATIE Schizophrenia Trials and for several subsequent trials funded through the NIMH-funded Schizophrenia Trials Network, as well as for the industry-funded Comparison of Atypicals for First Episode (CAFÉ) trial. He is currently the principal investigator for the NIMH-funded ACLAIMS (A Comparison of Long-Acting Injected Medications for Schizophrenia) trial. 

The Duke psychiatry residents have twice (1999 and 2002) selected Dr. McEvoy for their Honored Teacher Award. Dr. McEvoy received the Eugene A. Hargrove Mental Health Research Award in both 2002 and 2006, and the Pittsburgh Schizophrenia Conference Award in 2011. He is a Distinguished Life Fellow of the American Psychiatric Association.